LATS1 and neoplasm: In the context of CRC, Cheung et al. [254] used multiple mouse models—including MST1/2 deletion, LATS1/2 deletion, and YAP activation—to demonstrate that YAP activation inhibits tumor growth in APC loss-induced CRCs.